Mail

UK markets close in 3 hours 34 minutes

FTSE 100
8,427.18
+12.19(+0.14%)
FTSE 250
20,581.81
+21.47(+0.10%)
AIM
787.07
+0.41(+0.05%)
GBP/EUR
1.1628
-0.0006(-0.06%)
GBP/USD
1.2555
-0.0003(-0.03%)
Bitcoin GBP
49,211.05
-734.03(-1.47%)

What is the Lifetime ISA? How the retirement income option could help you

The lifetime ISA has real benefits for groups such as the self-employed

Sangui Biotech International, Inc. (SGBI)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0015

0.0000

(0.00%)

At close: 03:24PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	314.85k
Enterprise value	1.14M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.89
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	-0.33
52-week change ³	-65.12%
S&P500 52-week change ³	27.04%
52-week high ³	0.0200
52-week low ³	0.0012
50-day moving average ³	0.0015
200-day moving average ³	0.0024

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	209.9M
Implied shares outstanding ⁶	209.9M
Float ⁸	182.54M
% held by insiders ¹	13.04%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Jun 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-104.22%
Operating margin (ttm)	8.19%

Management effectiveness

Return on assets (ttm)	-35.47%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	96.26k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	221.40%
Gross profit (ttm)	N/A
EBITDA	-52.91k
Net income avi to common (ttm)	-100.32k
Diluted EPS (ttm)	-0.0000
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	5.58k
Total cash per share (mrq)	0
Total debt (mrq)	815.93k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.05
Book value per share (mrq)	-0.00

Cash flow statement

Operating cash flow (ttm)	24.64k
Levered free cash flow (ttm)	66.19k